Hongyi Chen

1.8k total citations · 1 hit paper
32 papers, 1.2k citations indexed

About

Hongyi Chen is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Hongyi Chen has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Hongyi Chen's work include Nanoplatforms for cancer theranostics (13 papers), Extracellular vesicles in disease (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Hongyi Chen is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Extracellular vesicles in disease (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Hongyi Chen collaborates with scholars based in China, South Korea and Portugal. Hongyi Chen's co-authors include Tao Sun, Peixin Liu, Yongchao Chu, Yiwen Zhang, Wenxi Zhou, Chao Li, Qin Guo, Chen Jiang, Chen Jiang and Yu Zhou and has published in prestigious journals such as Advanced Materials, ACS Nano and Renewable and Sustainable Energy Reviews.

In The Last Decade

Hongyi Chen

31 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

2020 356 citations Wenxi Zhou, Yu Zhou et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongyi Chen China	15	533	398	256	254	169	32	1.2k
Xi Yang China	26	743 1.4×	393 1.0×	147 0.6×	169 0.7×	212 1.3×	75	1.9k
Aili Zhang China	23	975 1.8×	306 0.8×	196 0.8×	159 0.6×	167 1.0×	51	1.4k
Shuo Yang China	28	1.2k 2.3×	417 1.0×	733 2.9×	202 0.8×	230 1.4×	80	2.3k
Dandan Fan China	20	821 1.5×	247 0.6×	517 2.0×	159 0.6×	170 1.0×	63	1.4k
Xiaoyan Wang China	20	427 0.8×	500 1.3×	151 0.6×	251 1.0×	353 2.1×	92	1.5k
Zhen Xing China	23	1.3k 2.4×	249 0.6×	652 2.5×	128 0.5×	193 1.1×	93	2.1k
Yuping Yang China	19	971 1.8×	177 0.4×	335 1.3×	122 0.5×	88 0.5×	88	1.6k
Una Riekstiņa Latvia	20	614 1.2×	181 0.5×	213 0.8×	93 0.4×	106 0.6×	39	1.2k
Li Su China	25	895 1.7×	224 0.6×	330 1.3×	182 0.7×	394 2.3×	82	2.0k

Countries citing papers authored by Hongyi Chen

Since Specialization

Citations

This map shows the geographic impact of Hongyi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyi Chen more than expected).

Fields of papers citing papers by Hongyi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyi Chen. The network helps show where Hongyi Chen may publish in the future.

Co-authorship network of co-authors of Hongyi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyi Chen. A scholar is included among the top collaborators of Hongyi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyi Chen. Hongyi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Hongyi, et al.. (2025). Collaborative Perception Against Data Fabrication Attacks in Vehicular Networks. IEEE Transactions on Mobile Computing. 24(10). 10654–10667. 1 indexed citations

Chen, Hongyi, Haolin Song, Chufeng Li, et al.. (2025). Cascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Advanced Science. 12(38). e07118–e07118. 2 indexed citations

Shen, Jiacheng, Yuxuan Fang, Nan Xu, et al.. (2025). Exploring the mechanism of triptolide inhibiting the motility of fibroblast-like synoviocytes in rheumatoid arthritis via RhoA/Rho-associated kinase axis, based on network pharmacology, molecular docking and molecular dynamics simulations. Frontiers in Pharmacology. 16. 1545514–1545514. 2 indexed citations

Xu, Jiayang, et al.. (2024). Raman Flow Cytometry and Its Biomedical Applications. Biosensors. 14(4). 171–171. 3 indexed citations

Xiao, Liang, et al.. (2024). Edge-Assisted Collaborative Perception Against Jamming and Interference in Vehicular Networks. IEEE Transactions on Wireless Communications. 24(1). 860–874. 1 indexed citations

Xiao, Liang, et al.. (2024). Reinforcement Learning Based Environment-Aware V2I Anti-Jamming Communications. IEEE Transactions on Vehicular Technology. 74(4). 6610–6623. 2 indexed citations

Chu, Yongchao, Boyu Su, Yifan Luo, et al.. (2023). Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness. Molecular Pharmaceutics. 20(3). 1591–1598. 3 indexed citations

Yang, Qingya, Fang Zhang, Hongyi Chen, et al.. (2023). The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment. Bioscience Reports. 44(1). 5 indexed citations

Zhao, Zhenhao, Chufeng Li, Yiwen Zhang, et al.. (2023). Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases. Bioactive Materials. 27. 474–487. 12 indexed citations

10.

Chen, Hongyi, Haolin Song, Yifan Luo, et al.. (2023). Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer. Advanced Functional Materials. 33(28). 29 indexed citations

11.

Zhao, Zhenhao, Yujie Zhang, Chao Li, et al.. (2022). Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis. Journal of Controlled Release. 349. 520–532. 19 indexed citations

12.

Chen, Hongyi, Tao Sun, & Chen Jiang. (2022). Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy. Journal of Controlled Release. 348. 572–589. 18 indexed citations

13.

Chen, Hongyi, Qin Guo, Yongchao Chu, et al.. (2022). Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Biomaterials. 287. 121599–121599. 61 indexed citations

14.

Chu, Yongchao, Yifan Luo, Boyu Su, et al.. (2022). A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy. Acta Pharmaceutica Sinica B. 13(1). 298–314. 34 indexed citations

15.

Wang, Yu, Qinjun Chen, Haolin Song, et al.. (2022). A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy. Small. 18(41). e2201704–e2201704. 41 indexed citations

16.

Liu, Peixin, Tongyu Zhang, Qinjun Chen, et al.. (2021). Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation. Advanced Materials. 33(26). e2100746–e2100746. 115 indexed citations

17.

Zhou, Wenxi, Han Y. H. Chen, Yu Zhou, et al.. (2021). Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Biomaterials. 280. 121306–121306. 67 indexed citations

18.

Zhou, Wenxi, Yu Zhou, Xinli Chen, et al.. (2020). Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 268. 120546–120546. 356 indexed citations breakdown →

19.

Sun, Tao, Guang‐Ping Zhang, Zhongyuan Guo, et al.. (2020). Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic. Journal of Controlled Release. 321. 483–496. 36 indexed citations

20.

Wang, Tianyue, Gaoxiang Wu, Jiewei Chen, et al.. (2016). Integration of solar technology to modern greenhouse in China: Current status, challenges and prospect. Renewable and Sustainable Energy Reviews. 70. 1178–1188. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact